Literature DB >> 17350581

Further evidence for BRCA1 communication with the inactive X chromosome.

Daniel P Silver1, Stoil D Dimitrov, Jean Feunteun, Rebecca Gelman, Ronny Drapkin, Shihua D Lu, Elena Shestakova, Soundarapandian Velmurugan, Nicholas Denunzio, Serban Dragomir, Jessica Mar, Xiaoling Liu, Sven Rottenberg, Jos Jonkers, Shridar Ganesan, David M Livingston.   

Abstract

BRCA1, a breast and ovarian cancer-suppressor gene, exerts tumor-suppressing functions that appear to be associated, at least in part, with its DNA repair, checkpoint, and mitotic regulatory activities. Earlier work from our laboratory also suggested an ability of BRCA1 to communicate with the inactive X chromosome (Xi) in female somatic cells (Ganesan et al., 2002). Xiao et al. (2007) (this issue of Cell) have challenged this conclusion. Here we discuss recently published data from our laboratory and others and present new results that, together, provide further support for a role of BRCA1 in the regulation of XIST concentration on Xi in somatic cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350581     DOI: 10.1016/j.cell.2007.02.025

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  31 in total

Review 1.  The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome.

Authors:  Eriona Hysolli; Yong Wook Jung; Yoshiaki Tanaka; Kun-Yong Kim; In-Hyun Park
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

2.  Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer.

Authors:  Stacey J Winham; Nicholas B Larson; Sebastian M Armasu; Zachary C Fogarty; Melissa C Larson; Brian M McCauley; Chen Wang; Kate Lawrenson; Simon Gayther; Julie M Cunningham; Brooke L Fridley; Ellen L Goode
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

Review 3.  New twists in X-chromosome inactivation.

Authors:  Jennifer A Erwin; Jeannie T Lee
Journal:  Curr Opin Cell Biol       Date:  2008-05-26       Impact factor: 8.382

4.  RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci.

Authors:  Yiduo Hu; Ralph Scully; Bijan Sobhian; Anyong Xie; Elena Shestakova; David M Livingston
Journal:  Genes Dev       Date:  2011-03-15       Impact factor: 11.361

5.  Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors.

Authors:  Sven Rottenberg; Marieke A Vollebergh; Bas de Hoon; Jorma de Ronde; Philip C Schouten; Ariena Kersbergen; Serge A L Zander; Marina Pajic; Janneke E Jaspers; Martijn Jonkers; Martin Lodén; Wendy Sol; Eline van der Burg; Jelle Wesseling; Jean-Pierre Gillet; Michael M Gottesman; Joost Gribnau; Lodewyk Wessels; Sabine C Linn; Jos Jonkers; Piet Borst
Journal:  Cancer Res       Date:  2012-03-06       Impact factor: 12.701

Review 6.  Mechanisms of BRCA1 tumor suppression.

Authors:  Daniel P Silver; David M Livingston
Journal:  Cancer Discov       Date:  2012-07-27       Impact factor: 39.397

7.  Condensin complexes regulate mitotic progression and interphase chromatin structure in embryonic stem cells.

Authors:  Thomas G Fazzio; Barbara Panning
Journal:  J Cell Biol       Date:  2010-02-22       Impact factor: 10.539

Review 8.  Guided by RNAs: X-inactivation as a model for lncRNA function.

Authors:  John E Froberg; Lin Yang; Jeannie T Lee
Journal:  J Mol Biol       Date:  2013-06-28       Impact factor: 5.469

9.  BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.

Authors:  Julian Puppe; Rinske Drost; Xiaoling Liu; Simon A Joosse; Bastiaan Evers; Paulien Cornelissen-Steijger; Petra Nederlof; Qiang Yu; Jos Jonkers; Maarten van Lohuizen; Alexandra M Pietersen
Journal:  Breast Cancer Res       Date:  2009-08-26       Impact factor: 6.466

10.  Misbehaviour of XIST RNA in breast cancer cells.

Authors:  Silvia M Sirchia; Silvia Tabano; Laura Monti; Maria P Recalcati; Manuela Gariboldi; Francesca R Grati; Giovanni Porta; Palma Finelli; Paolo Radice; Monica Miozzo
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.